Should You Hold Collegium Pharmaceutical Inc (COLL) in Drug Manufacturers

The 75 rating InvestorsObserver gives to Collegium Pharmaceutical Inc (COLL) stock puts it near the top of the Drug Manufacturers - Specialty & Generic industry. In addition to scoring higher than 98 percent of stocks in the Drug Manufacturers - Specialty & Generic industry, COLL’s 75 overall rating means the stock scores better than 75 percent of all stocks.

COLL has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on COLL!

See Full COLL Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 75 would rank higher than 75 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Collegium Pharmaceutical Inc Stock Today?

Collegium Pharmaceutical Inc (COLL) stock is up 0.76% while the S&P 500 has fallen -0.73% as of 11:59 AM on Friday, Oct 20. COLL is up $0.16 from the previous closing price of $21.19 on volume of 54,669 shares. Over the past year the S&P 500 is up 15.85% while COLL is up 27.08%. COLL lost -$0.41 per share the over the last 12 months. Click Here to get the full Stock Report for Collegium Pharmaceutical Inc stock.